Nektar Therapeutics (NKTR)

Last Closing Price: 32.54 (2026-11-19)

Weighted-Average Shares Outstanding (Diluted) (Quarterly)

Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.

Nektar Therapeutics (NKTR) had Weighted-Average Shares Outstanding (Diluted) of 34.18M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$9.39M
$-55.65M
--
$9.39M
$67.19M
$-57.80M
$2.76M
$-55.05M
$-55.05M
$-55.07M
$-55.65M
$-55.65M
$-55.07M
$-57.80M
$-61.16M
34.18M
Weighted-Average Shares Outstanding (Diluted)
34.18M
$-1.63
$-1.63
Balance Sheet Financials
$679.33M
--
$357.92M
$1.04B
$75.48M
--
$112.05M
$187.53M
$849.72M
$849.72M
$849.72M
34.21M
Cash Flow Statement Financials
$-192.00M
$-683.00M
$894.57M
$15.12M
$34.69M
$19.57M
$10.47M
--
--
Fundamental Metrics & Ratios
9.00
--
--
--
--
100.00%
-615.83%
-615.83%
--
-586.47%
-592.91%
$-192.51M
--
--
--
0.01
--
--
--
-6.55%
-6.55%
-5.37%
-6.55%
$24.84
$-5.63
$-5.62